Decreasing fluconazole susceptibility of clinical South African Cryptococcus neoformans isolates over a decade

BACKGROUND: Fluconazole is used in combination with amphotericin B for induction treatment of cryptococcal meningitis and as monotherapy for consolidation and maintenance treatment. More than 90% of isolates from first episodes of cryptococcal disease had a fluconazole minimum inhibitory concentrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Naicker, Serisha D., Mpembe, Ruth S., Maphanga, Tsidiso G., Zulu, Thokozile G., Desanto, Daniel, Wadula, Jeannette, Mvelase, Nomonde, Maluleka, Caroline, Reddy, Kessendri, Dawood, Halima, Maloba, Motlatji, Govender, Nelesh P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108701/
https://www.ncbi.nlm.nih.gov/pubmed/32231354
http://dx.doi.org/10.1371/journal.pntd.0008137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108701/
https://www.ncbi.nlm.nih.gov/pubmed/32231354
http://dx.doi.org/10.1371/journal.pntd.0008137

Ejemplares similares